nodes	percent_of_prediction	percent_of_DWPC	metapath
Temozolomide—Rigors—Metformin—metabolic syndrome X	0.0433	0.0433	CcSEcCtD
Temozolomide—Neuropathy—Metformin—metabolic syndrome X	0.0332	0.0332	CcSEcCtD
Temozolomide—Ear pain—Metformin—metabolic syndrome X	0.0301	0.0301	CcSEcCtD
Temozolomide—Nasal congestion—Metformin—metabolic syndrome X	0.0282	0.0282	CcSEcCtD
Temozolomide—Dehydration—Metformin—metabolic syndrome X	0.0239	0.0239	CcSEcCtD
Temozolomide—Breast disorder—Metformin—metabolic syndrome X	0.0232	0.0232	CcSEcCtD
Temozolomide—Abdominal distension—Metformin—metabolic syndrome X	0.0223	0.0223	CcSEcCtD
Temozolomide—Sweating increased—Metformin—metabolic syndrome X	0.0216	0.0216	CcSEcCtD
Temozolomide—Neutropenia—Metformin—metabolic syndrome X	0.0208	0.0208	CcSEcCtD
Temozolomide—Upper respiratory tract infection—Metformin—metabolic syndrome X	0.0206	0.0206	CcSEcCtD
Temozolomide—Infestation—Metformin—metabolic syndrome X	0.0198	0.0198	CcSEcCtD
Temozolomide—Infestation NOS—Metformin—metabolic syndrome X	0.0198	0.0198	CcSEcCtD
Temozolomide—Neuropathy peripheral—Metformin—metabolic syndrome X	0.0194	0.0194	CcSEcCtD
Temozolomide—Hepatobiliary disease—Metformin—metabolic syndrome X	0.0187	0.0187	CcSEcCtD
Temozolomide—Hepatitis—Metformin—metabolic syndrome X	0.0178	0.0178	CcSEcCtD
Temozolomide—Hypoaesthesia—Metformin—metabolic syndrome X	0.0177	0.0177	CcSEcCtD
Temozolomide—Oedema peripheral—Metformin—metabolic syndrome X	0.0175	0.0175	CcSEcCtD
Temozolomide—Connective tissue disorder—Metformin—metabolic syndrome X	0.0175	0.0175	CcSEcCtD
Temozolomide—Eye disorder—Metformin—metabolic syndrome X	0.0166	0.0166	CcSEcCtD
Temozolomide—Flushing—Metformin—metabolic syndrome X	0.0165	0.0165	CcSEcCtD
Temozolomide—Cardiac disorder—Metformin—metabolic syndrome X	0.0165	0.0165	CcSEcCtD
Temozolomide—Angiopathy—Metformin—metabolic syndrome X	0.0161	0.0161	CcSEcCtD
Temozolomide—Immune system disorder—Metformin—metabolic syndrome X	0.016	0.016	CcSEcCtD
Temozolomide—Mediastinal disorder—Metformin—metabolic syndrome X	0.016	0.016	CcSEcCtD
Temozolomide—Chills—Metformin—metabolic syndrome X	0.0159	0.0159	CcSEcCtD
Temozolomide—Erythema—Metformin—metabolic syndrome X	0.0155	0.0155	CcSEcCtD
Temozolomide—Malnutrition—Metformin—metabolic syndrome X	0.0155	0.0155	CcSEcCtD
Temozolomide—Dysgeusia—Metformin—metabolic syndrome X	0.0151	0.0151	CcSEcCtD
Temozolomide—Vision blurred—Metformin—metabolic syndrome X	0.0146	0.0146	CcSEcCtD
Temozolomide—Tremor—Metformin—metabolic syndrome X	0.0145	0.0145	CcSEcCtD
Temozolomide—Ill-defined disorder—Metformin—metabolic syndrome X	0.0143	0.0143	CcSEcCtD
Temozolomide—Malaise—Metformin—metabolic syndrome X	0.0139	0.0139	CcSEcCtD
Temozolomide—Palpitations—Metformin—metabolic syndrome X	0.0137	0.0137	CcSEcCtD
Temozolomide—Hypertension—Metformin—metabolic syndrome X	0.0133	0.0133	CcSEcCtD
Temozolomide—Myalgia—Metformin—metabolic syndrome X	0.0132	0.0132	CcSEcCtD
Temozolomide—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.0131	0.0131	CcSEcCtD
Temozolomide—Discomfort—Metformin—metabolic syndrome X	0.013	0.013	CcSEcCtD
Temozolomide—Oedema—Metformin—metabolic syndrome X	0.0126	0.0126	CcSEcCtD
Temozolomide—Infection—Metformin—metabolic syndrome X	0.0125	0.0125	CcSEcCtD
Temozolomide—Nervous system disorder—Metformin—metabolic syndrome X	0.0124	0.0124	CcSEcCtD
Temozolomide—Thrombocytopenia—Metformin—metabolic syndrome X	0.0124	0.0124	CcSEcCtD
Temozolomide—Skin disorder—Metformin—metabolic syndrome X	0.0123	0.0123	CcSEcCtD
Temozolomide—Hyperhidrosis—Metformin—metabolic syndrome X	0.0122	0.0122	CcSEcCtD
Temozolomide—Anorexia—Metformin—metabolic syndrome X	0.012	0.012	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.0115	0.0115	CcSEcCtD
Temozolomide—Paraesthesia—Metformin—metabolic syndrome X	0.0113	0.0113	CcSEcCtD
Temozolomide—Dyspnoea—Metformin—metabolic syndrome X	0.0113	0.0113	CcSEcCtD
Temozolomide—Somnolence—Metformin—metabolic syndrome X	0.0112	0.0112	CcSEcCtD
Temozolomide—Dyspepsia—Metformin—metabolic syndrome X	0.0111	0.0111	CcSEcCtD
Temozolomide—Decreased appetite—Metformin—metabolic syndrome X	0.011	0.011	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.0109	0.0109	CcSEcCtD
Temozolomide—Fatigue—Metformin—metabolic syndrome X	0.0109	0.0109	CcSEcCtD
Temozolomide—Constipation—Metformin—metabolic syndrome X	0.0108	0.0108	CcSEcCtD
Temozolomide—Feeling abnormal—Metformin—metabolic syndrome X	0.0104	0.0104	CcSEcCtD
Temozolomide—Gastrointestinal pain—Metformin—metabolic syndrome X	0.0103	0.0103	CcSEcCtD
Temozolomide—Urticaria—Metformin—metabolic syndrome X	0.01	0.01	CcSEcCtD
Temozolomide—Abdominal pain—Metformin—metabolic syndrome X	0.00998	0.00998	CcSEcCtD
Temozolomide—Asthenia—Metformin—metabolic syndrome X	0.00905	0.00905	CcSEcCtD
Temozolomide—Pruritus—Metformin—metabolic syndrome X	0.00893	0.00893	CcSEcCtD
Temozolomide—Diarrhoea—Metformin—metabolic syndrome X	0.00863	0.00863	CcSEcCtD
Temozolomide—Dizziness—Metformin—metabolic syndrome X	0.00834	0.00834	CcSEcCtD
Temozolomide—Vomiting—Metformin—metabolic syndrome X	0.00802	0.00802	CcSEcCtD
Temozolomide—Rash—Metformin—metabolic syndrome X	0.00796	0.00796	CcSEcCtD
Temozolomide—Dermatitis—Metformin—metabolic syndrome X	0.00795	0.00795	CcSEcCtD
Temozolomide—Headache—Metformin—metabolic syndrome X	0.00791	0.00791	CcSEcCtD
Temozolomide—Nausea—Metformin—metabolic syndrome X	0.0075	0.0075	CcSEcCtD
